Altrinsic Global Advisors LLC Applied Genetic Technologies Corp Transaction History

Altrinsic Global Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.07 - $2.71 $403,283 - $1.02 Million	-376,900 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.94 - $8.19 $157,600 - $327,600	40,000 Added 11.87%	376,900 $1.91 Million
Q1 2020 May 14, 2020	BUY	$2.36 - $9.86 $70,800 - $295,800	30,000 Added 9.78%	336,900 $1.11 Million
Q1 2019 May 14, 2019	BUY	$2.62 - $4.44 $157,200 - $266,400	60,000 Added 24.3%	306,900 $1.29 Million
Q1 2018 May 14, 2018	BUY	$3.65 - $5.2 $65,335 - $93,080	17,900 Added 7.82%	246,900 $951,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $812,950 - $1.2 Million	229,000	229,000 $905,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.